0001213900-24-020088.txt : 20240305 0001213900-24-020088.hdr.sgml : 20240305 20240305152052 ACCESSION NUMBER: 0001213900-24-020088 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240114 FILED AS OF DATE: 20240305 DATE AS OF CHANGE: 20240305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HULL ANDREW CENTRAL INDEX KEY: 0001818252 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39685 FILM NUMBER: 24719915 MAIL ADDRESS: STREET 1: C/O INMED PHARMACEUTICALS INC. STREET 2: SUITE 310 - 815 HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001728328 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 BUSINESS PHONE: (604) 669-7207 MAIL ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 4 1 ownership.xml OWNERSHIP DOCUMENT X0508 4 2024-01-14 0 0001728328 InMed Pharmaceuticals Inc. INM 0001818252 HULL ANDREW C/O INMED PHARMACEUTICALS INC. 310-815 WEST HASTINGS ST. VANCOUVER A1 V6C1B4 BRITISH COLUMBIA, CANADA 1 0 0 0 0 Employee Stock Option (Expiration) 307.01 2024-01-14 4 H 0 42 0.00 D 2019-01-14 2024-01-14 Common shares 42 8542 D Converted from the Canadian dollar exercise price of C$412.50 using an exchange rate of C$1.3436 = $US1.00 /s/ Eric A Adams, attorney-in-fact for Mr. Andrew Hull 2024-03-05